3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Myelodysplastic Syndromes
4
Leukemia, Myeloid, Acute
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Neuroblastoma
3
Lymphoma, Large B-Cell, Diffuse
3
Recurrence
2
Neoplasms, Germ Cell and Embryonal
2
Multiple Myeloma
2
Lymphoma, Follicular
2
Lymphoma
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia
2
Hepatoblastoma
2
Glioblastoma
2
Breast Neoplasms
2
Brain Neoplasms
2
Anemia, Refractory, with Excess of Blasts
2
Wilms Tumor
1
Uveal Melanoma
1
Skin Neoplasms
1
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Prostatic Neoplasms
1
Primary Malignant Peripheral Nerve Sheath Tumors
1
Ototoxicity
1
Oligodendroglioma
1
Neoplasm Metastasis
1
Mycosis Fungoides
1
Melanoma
1
Lymphoma, T-Cell, Cutaneous
1
Interventions
ruxolitinib
7
fludarabine phosphate
3
bomedemstat
3
Whole-Body Irradiation
3
Tacrolimus
3
Specimen Handling
3
Mycophenolic Acid
3
Cyclophosphamide
3
Biopsy
3
fludarabine
2
Stem Cell Transplantation
2
Peripheral Blood Stem Cell Transplantation
2
Methotrexate
2
Melphalan
2
Injections
2
Busulfan
2
venetoclax
1
veliparib
1
piperine
1
pevonedistat
1
iadademstat
1
fedratinib
1
demethoxycurcumin
1
decitabine and cedazuridine drug combination
1
anagrelide
1
X-Rays
1
Valganciclovir
1
Transplantation
1
Topotecan
1
Therapeutics
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Thrombocythemia, Essential
×
Vorinostat
×
1 year
×
Clear all
No trials found.